Phoenix Children’s is one of a small number of centers in the United States that have integrated intensive care multimodal monitoring (MMM) into our patient care, setting us apart from other neurocritical care programs across the U.S. Advanced neurocritical care monitoring is crucial for the advanced care of patients with brain injuries in the intensive care unit. Our monitoring provides timely and personalized care for children with acute brain injuries.
Multimodal monitoring is the continuous, real-time evaluation of brain and systemic functions in patients with critical illnesses. This state-of-the-art technology provides physicians with real-time information about multiple neurological and physiological changes in patients who have serious neurological injuries or are at risk for these injuries. It is considered an extension of the clinical examination, and it helps guide physicians by:
- Detecting early signs of brain injury before irreversible damage occurs.
- Enhancing understanding of various physiological processes affecting brain function such as cerebrovascular pressure reactivity, carbon dioxide reactivity, brain compliance, cortical and corticothalamic function and autonomic function.
- Guiding the design and implementation of clinical management and research protocols.
- Improving neurological outcomes and quality of life in people with severe brain injuries.
- Monitoring the effectiveness of neuroprotective therapies and analyze responses to avoid potential adverse effects.
- Providing opportunities for neurocritical care teams to set individualized goals for patient care and patient management.
Multimodal monitoring can improve outcomes for patients with critical conditions and those at risk. It's becoming a key tool in clinical decision-making for neurocritical care.
